Nanox.ARC distribution push targets 300 U.S. systems
Relevant. Nanox.ARC is an FDA-cleared multisource digital tomosynthesis system intended to expand 3D imaging access across healthcare and public sector settings.
Nano-X Imaging has signed 2 U.S. distribution agreements to expand deployment of its Nanox.ARC multisource digital tomosynthesis system. The agreements involve Howard Technology Solutions and Radiology Oncology Systems.
The Howard agreement calls for 300 systems to be marketed and deployed across the U.S. over 3 years. Nanox said 60 systems are planned for the first year.
Howard Technology Solutions will introduce the system to healthcare facilities and public sector customers through its national network. The company is a division of Howard Industries and provides technology procurement, deployment, and support services.
The second agreement names Radiology Oncology Systems as a U.S. distribution partner. The company will support commercial rollout of the system across hospitals and clinics, with a focus on oncology-adjacent care environments.
Nanox described the system as an FDA-cleared, multisource digital tomosynthesis platform. The company said it is designed to make 3D imaging available in more clinical settings at lower cost and reduced radiation dose compared with traditional CT.
In its fourth-quarter 2025 business update, Nanox said it had distribution agreements for approximately 360 Nanox.ARC systems in the U.S. over the next 2 to 3 years. The company said timing depends on regulatory, operational, and market factors.
Company:Nanox
Nanox coverage
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
Niowave Lansing site to scale Ac-225 supply by 2028
The Lansing, MI, site will house superconducting linear accelerators and radiochemistry systems to support scalable actinium-225 production, with completion expected in 2028.
30-year GE-UW tie expands into CT and theranostics research
The collaboration will focus on CT and molecular imaging technologies for cardiology, oncology, and theranostics workflows at UW Medicine Radiology facilities in Seattle.
Recall issues and isotope shortages weigh on Radnostix Q1 revenue
The radioisotope-focused company reported $2.38M in Q1 revenue, citing recall impacts, isotope shortages, and Cobalt-60 hot cell downtime.
Ephemeral to build AI data platform for Plus CNS oncology programs
The companies will develop an AI platform to integrate therapeutic, diagnostic, and bioinformatics data across Plus Therapeutics’ CNS oncology programs.
Fujifilm balloon-free EBUS scope targets pulmonary setup time
The EB-710US Ultrasound Bronchoscope is designed for pulmonary procedures and will be demonstrated at the American Thoracic Society Conference.
ACIST Pro brings contrast tracking upgrade to U.S. cath labs
The Bracco company received U.S. clearance and launched ACIST Pro, a variable-rate contrast management system for image-guided cardiovascular procedures.
Braid Health launches $199 radiology second-opinion service
Patients can upload MRI, CT, X-ray, or ultrasound files and receive a written second opinion from a board-certified U.S. radiologist.
QT Imaging prices $10M raise for breast imaging platform
QT Imaging Holdings priced a $10M underwritten public offering of common stock and pre-funded warrants. The breast imaging technology company plans to use proceeds for working capital and general corporate purposes.
PSMA PET guidance anchors EDAP-Telix HIFU prostate work
EDAP TMS and Telix Pharmaceuticals signed a letter of intent to explore clinical research combining Focal One Robotic HIFU with Telix PSMA PET imaging agents in prostate cancer care.
UnitedHealthcare cites radiology costs in Maryland premium request
UnitedHealthcare is seeking an average 7.9% mid-year premium increase for some Maryland small-group plans. The insurer cited rising outpatient costs, including radiology, lab pathology, infusion, and radiation therapy.
Lumexa adds 4 imaging centers, including first UPMC JV site
Lumexa Imaging added 4 outpatient imaging centers across Pennsylvania, North Carolina, South Carolina, and Florida. The expansion includes acquired centers through joint ventures with UPMC and Advocate Health, plus 2 newly built locations.
PAI report finds 82% of U.S. physicians are now employed
A new PAI-Avalere report found that 82% of U.S. physicians are employed by hospitals, health systems, or corporate entities. Physician-owned settings now account for 18% of physicians and 36.1% of practices.